Medical journals are corrupted by dependence on drug companiesBMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7501.1169-b (Published 19 May 2005) Cite this as: BMJ 2005;330:1169
- Zosia Kmietowicz
Medical journals are no more than “an extension of the marketing arm of pharmaceutical companies” because a large proportion of their revenue comes from drug advertisements and reprints of company funded trials, claims former BMJ editor, Richard Smith.
Dr Smith argues that although medical journals make a sizeable income from drug advertisements this is the least of their “corrupting form of dependence” on the industry since the advertisements are “there for all to see and criticize” (PLoS Medicine 2005;2:e138; www.plosmedicine.org, doi: 10.1371/journal.pmed.0020138).
Dr Smith's strongest criticism is levelled at the fact that journals publish …
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.